ITRM20040098A1 - Anticorpi oligoclonali anticlasterina per la diagnosi di neoplasie e la predizione del loro grado di malignita', metodo diagnostico e kit relativi. - Google Patents

Anticorpi oligoclonali anticlasterina per la diagnosi di neoplasie e la predizione del loro grado di malignita', metodo diagnostico e kit relativi.

Info

Publication number
ITRM20040098A1
ITRM20040098A1 IT000098A ITRM20040098A ITRM20040098A1 IT RM20040098 A1 ITRM20040098 A1 IT RM20040098A1 IT 000098 A IT000098 A IT 000098A IT RM20040098 A ITRM20040098 A IT RM20040098A IT RM20040098 A1 ITRM20040098 A1 IT RM20040098A1
Authority
IT
Italy
Prior art keywords
prediction
diagnosis
diagnostic method
antibodies
clasterine
Prior art date
Application number
IT000098A
Other languages
English (en)
Inventor
Elena Bonanno
Gennaro Citro
Flavia Pichiorri
Sabina Pucci
Luigi Giusto Spagnoli
Original Assignee
Univ Roma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Roma filed Critical Univ Roma
Priority to IT000098A priority Critical patent/ITRM20040098A1/it
Publication of ITRM20040098A1 publication Critical patent/ITRM20040098A1/it
Priority to AT05718998T priority patent/ATE553127T1/de
Priority to EP05718998A priority patent/EP1718676B1/en
Priority to PCT/IT2005/000088 priority patent/WO2005080434A1/en
Priority to US10/590,479 priority patent/US8357494B2/en

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57407—Specifically defined cancers
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/30—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/30—Immunoglobulins specific features characterized by aspects of specificity or valency
    • C07K2317/34—Identification of a linear epitope shorter than 20 amino acid residues or of a conformational epitope defined by amino acid residues

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Urology & Nephrology (AREA)
  • General Health & Medical Sciences (AREA)
  • Hematology (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • Organic Chemistry (AREA)
  • Cell Biology (AREA)
  • Oncology (AREA)
  • Food Science & Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Microbiology (AREA)
  • Biophysics (AREA)
  • Hospice & Palliative Care (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
IT000098A 2004-02-25 2004-02-25 Anticorpi oligoclonali anticlasterina per la diagnosi di neoplasie e la predizione del loro grado di malignita', metodo diagnostico e kit relativi. ITRM20040098A1 (it)

Priority Applications (5)

Application Number Priority Date Filing Date Title
IT000098A ITRM20040098A1 (it) 2004-02-25 2004-02-25 Anticorpi oligoclonali anticlasterina per la diagnosi di neoplasie e la predizione del loro grado di malignita', metodo diagnostico e kit relativi.
AT05718998T ATE553127T1 (de) 2004-02-25 2005-02-17 Oligoklonale anti-clusterin-antikörper zur diagnose und vorhersage der aggressivität von tumoren, diagnostisches verfahren und damit in zusammenhang stehende kits
EP05718998A EP1718676B1 (en) 2004-02-25 2005-02-17 Anti-clusterin oligoclonal antibodies for diagnosis and prediction of the aggressiveness of tumours, diagnostic method and related kits
PCT/IT2005/000088 WO2005080434A1 (en) 2004-02-25 2005-02-17 Anti-clusterin oligoclonal antibodies for diagnosis and prediction of the aggressiveness of tumours, diagnostic method and related kits
US10/590,479 US8357494B2 (en) 2004-02-25 2005-02-17 Anti-clusterin oligoclonal antibodies for diagnosis and prediction of the aggressiveness of tumours, diagnostic method and related kits

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT000098A ITRM20040098A1 (it) 2004-02-25 2004-02-25 Anticorpi oligoclonali anticlasterina per la diagnosi di neoplasie e la predizione del loro grado di malignita', metodo diagnostico e kit relativi.

Publications (1)

Publication Number Publication Date
ITRM20040098A1 true ITRM20040098A1 (it) 2004-05-25

Family

ID=34878864

Family Applications (1)

Application Number Title Priority Date Filing Date
IT000098A ITRM20040098A1 (it) 2004-02-25 2004-02-25 Anticorpi oligoclonali anticlasterina per la diagnosi di neoplasie e la predizione del loro grado di malignita', metodo diagnostico e kit relativi.

Country Status (5)

Country Link
US (1) US8357494B2 (it)
EP (1) EP1718676B1 (it)
AT (1) ATE553127T1 (it)
IT (1) ITRM20040098A1 (it)
WO (1) WO2005080434A1 (it)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7972770B2 (en) * 2005-08-16 2011-07-05 Memorial Sloan-Kettering Cancer Center Methods of detection of cancer using peptide profiles
WO2007030930A1 (en) * 2005-09-13 2007-03-22 National Research Council Of Canada Methods and compositions for modulating tumor cell activity
US7923253B2 (en) * 2007-11-05 2011-04-12 Battelle Memorial Institute Method for identifying type I diabetes mellitus in humans
CA2756570C (en) * 2009-04-17 2019-04-30 National Research Council Of Canada Peptide ligands for clusterin and uses thereof
CA2928846A1 (en) 2009-11-24 2011-06-03 Alethia Biotherapeutics Inc. Anti-clusterin antibodies and antigen binding fragments and their use to reduce tumor volume
JP2015512877A (ja) 2012-02-22 2015-04-30 アレシア・バイオセラピューティクス・インコーポレーテッド 癌を治療するためのクラステリン阻害剤とｅｇｆｒ阻害剤の併用
KR102462056B1 (ko) * 2015-04-30 2022-11-02 아이덱스 래보러토리즈, 인코포레이티드 클루스테린 아이소폼의 특이적 검출
SG11202103124WA (en) * 2018-10-23 2021-04-29 Glycardial Diagnostics S L Antibodies specific for glycosylated apoj and uses thereof

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5663315A (en) * 1994-12-06 1997-09-02 Alphagene, Inc. Isolated DNA encoding human GP2
US6930085B2 (en) 2002-04-05 2005-08-16 The Regents Of The University Of California G-type peptides to ameliorate atherosclerosis

Also Published As

Publication number Publication date
US8357494B2 (en) 2013-01-22
US20080317771A1 (en) 2008-12-25
EP1718676A1 (en) 2006-11-08
EP1718676B1 (en) 2012-04-11
WO2005080434A1 (en) 2005-09-01
ATE553127T1 (de) 2012-04-15

Similar Documents

Publication Publication Date Title
ATE488530T1 (de) Internalisierende antikörper spezifisch für das raag10 zelloberflächenziel
EA201100231A1 (ru) Диагностический анализ на основе антител
PH12016500658B1 (en) Human anti-alpha-synuclein autoantibodies
CY1119112T1 (el) K-ras μεταλλαξεις και θεραπεια anti-egfr αντισωματος
CY1118880T1 (el) Ανθρωπινα anti-il-23 αντισωματα, συνθεσεις, μεθοδοι και χρησεις
DK2135881T3 (da) Antistoffer, som binder til det tumor-associerede antigen TAT10772, til diagnose og behandling af tumor
IL184803A0 (en) Antibodies that bind to epha2 and methods of use thereof
EA200800094A1 (ru) Антитела cd19 и их использование
WO2007103770A8 (en) Compositions and methods for analyzing renal cancer
BRPI0407680A (pt) métodos para diagnóstico de cáncer e diminuição de metástase por células cancerosas
ATE553778T1 (de) Für humanes hepcidin spezifische antikörper
DE60224346D1 (de) Monoklonales Antikörper gegen das HCV Kernantigen
WO2009055820A3 (en) Salivary protein biomarkers for human oral cancer
EP2210939A4 (en) ANTIBODY ANTI-BST2
ATE553127T1 (de) Oligoklonale anti-clusterin-antikörper zur diagnose und vorhersage der aggressivität von tumoren, diagnostisches verfahren und damit in zusammenhang stehende kits
MX2008008185A (es) Antigenos de acido des-n-acetil-sialico, anticuerpos para los mismos, y metodos de uso en la terapia de cancer.
DK2054443T3 (da) Antistoffer mod en epitop fra AGR2, assays og hybridomer
EA200970884A1 (ru) Способы лечения рака путем введения комбинаций человеческого интерлейкина ил-18
WO2009003082A3 (en) Immunological compositions as cancer biomarkers and/or therapeutics
GB0706558D0 (en) Diagnostic assay
WO2006091326A8 (en) Anti-prl-3 antibodies and methods of use thereof
WO2002055555A3 (en) Antigenic ck-18 compounds for therapy and diagnosis and methods for using same
UA98632C2 (ru) Антагонистические антитела к notch3 и их применение для профилактики и лечения связанных с notch3 заболеваний
DE602007011206D1 (de) Gpr30-östrogenrezeptor bei mammakarzinomen
EA200600012A1 (ru) Полиморфизм человеческого гена nbs1, полезный для диагностики наследственной предрасположенности к раку